Skip to content

Nature Biotechnology

Peer-reviewed scientific journal publishing research on biotechnology, including genomics, drug development, and therapeutic engineering.

Known aliases

  • Nat Biotechnol
  • Nat. Biotechnol.
  • Nature Biotech

Current stories

scienceOne report1 publisher

HitSV adds 31.5% to the 1KGP phase 4 structural-variant callset

HitSV, a new structural-variant caller, posted genotype F1 scores 10% to 72% above existing callers on the HG002 benchmark. The same abstract reports a 31.5% larger 1KGP phase 4 callset, and HG002 F1 is the only accuracy figure it reports.

Publishers:nature.com

Reality

Evidence55
Adoption
Not scored
Hype gap+20
Incentives
Not scored
Confidence50
scienceOne report1 publisher

Calibrated metrics put AI virtual cell models ahead of simple baselines

Shift Bioscience reports in Nature Biotechnology that deep learning perturbation models often beat simple baselines once the metric can detect a biological signal. A model that looked no better than a baseline may just have been scored with a metric too blunt to tell.

Publishers:genengnews.com

Reality

Evidence55
Adoption12
Hype gap+20
Incentives70
Confidence50
scienceOne report1 publisher

Shotgun DNA delivery screens millions of metabolic pathways in mammalian cells at once

Trolle and colleagues screened millions of synthetic metabolic pathways at once and grew hamster cells without the essential amino acid valine. Their method, shotgun genetic engineering, breaks the slow build-and-test loop that had confined such work to fast-growing microbes.

Publishers:nature.com

Reality

Evidence62
Adoption
Not scored
Hype gap+10
Incentives55
Confidence58
scienceOne report1 publisher

Bird-genome search yields 159 RNA-only tools for inserting genes in human cells

Researchers found 159 R2 retrotransposons in 1,139 avian genomes and engineered variants that reached up to 60% gene insertion in human primary cells. These are RNA-only tools, able to add a gene to the genome without delivering any DNA to the cell.

Publishers:nature.com

Reality

Evidence58
Adoption
Not scored
Hype gap+10
Incentives50
Confidence55
scienceOne report1 publisher

AI-tuned nanoparticle recipe keeps mRNA vaccines stable for a year at room temperature

MIT researchers used an AI algorithm to reformulate mRNA vaccine nanoparticles that stay stable for a year at room temperature and two months near 38C. In mice the shots matched a Moderna-like vaccine. The lab says the change could loosen the ultracold cold chain.

Publishers:news.mit.edu phys.org

Reality

Evidence50
Adoption
Not scored
Hype gap+20
Incentives40
Confidence55
productConfirmed3 publishers

Six independently built ageing clocks agree on the same 42 patients from Insilico's lung trial

The six clocks agreeing matters more than the years they report, because a drug that quiets an inflamed lung moves the same blood proteins whether or not it slows ageing anywhere else.

Perspective Coverage

3 publishers
Builder
Builder 45%
Operator
Operator 32%
Investor
Investor 23%

Reality

Evidence42
Adoption5
Hype gap+45
Incentives70
Confidence62
scienceOne report1 publisher

Siderophore-engineered bacteria weather olivine 2.6 times faster in flowing seawater

Enhanced rock weathering's problem has always been rate rather than chemistry, and a Nature Biotechnology result attacks the rate directly. The 2.6-fold gain was measured on kilograms of mineral in a flow reactor.

Publishers:genengnews.com

Reality

Evidence52
Adoption12
Hype gap+44
Incentives58
Confidence50
scienceOne report1 publisher

Basel's tree-shaped embedding argues your flat single-cell maps have been showing you artifacts

A University of Basel group has published Bonsai in Nature Biotechnology, replacing the two-dimensional map with a branching tree. The fidelity gains are asserted qualitatively, not quantified.

Publishers:phys.org

Reality

Evidence34
Adoption11
Hype gap+38
Incentives66
Confidence44
scienceOne report1 publisher

Harvard's KinoPlex cuts 1.8 million phosphorylation sites down to 250,000 plausible ones

The atlas turns kinase-inhibitor selection into a matching problem. What is missing is evidence that the match predicts which drug works in a patient.

Publishers:phys.org

Reality

Evidence55
Adoption22
Hype gap+18
Incentives68
Confidence45
scienceOne report1 publisher

AI antibody design clears one task in three in first blinded benchmark

AIntibody tested 511 antibodies from 29 organizations on three tasks. Ranking clones inside HCDR3 clusters was worse than random for every model but one.

Publishers:nature.com

Reality

Evidence76
Adoption38
Hype gap+42
Incentives55
Confidence62
scienceOne report1 publisher

One pot, 1,000 gene fragments: the DNA writing bottleneck starts to move

A Nature Biotechnology paper reports a hybridization-driven synthesis method that builds over 1,000 distinct gene fragments in a single reaction, then uses it to find PETase variants beating the standard enzyme.

Publishers:nature.com

Reality

Evidence57
Adoption
Not scored
Hype gap+22
Incentives62
Confidence50
scienceOne report1 publisher

Viral RNA snippets triple linear mRNA half-life in cells, IBS team reports in Cell

A screen of 337 virus genomes found stabilizing elements; one, Pt1, pushed linear mRNA half-life from 7.6 to 23.1 hours by recruiting nuclear poly(A) polymerases in the cytoplasm.

Publishers:phys.org

Reality

Evidence58
Adoption
Not scored
Hype gap+22
Incentives66
Confidence52